Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by 4D pharma

Update on Suspension of Trading
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma to Present at the H.C. Wainwright Global Investment Conference
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics Summit
From 4D pharma
Via Business Wire
Tickers LBPS
4D pharma to Participate in Upcoming Virtual Investor Conferences in September
From 4D pharma
Via Business Wire
Tickers LBPS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.